Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CD59 antibody (full length)

This Mouse Monoclonal antibody specifically detects CD59 in IHC (p). It exhibits reactivity toward Human.
Catalog No. ABIN3025487
$640.46
Plus shipping costs $50.00
100 μg
Shipping to: United States
Delivery in 2 to 4 Business Days

Quick Overview for CD59 antibody (full length) (ABIN3025487)

Target

See all CD59 Antibodies
CD59

Reactivity

  • 192
  • 17
  • 11
  • 11
  • 5
  • 4
  • 3
  • 1
  • 1
Human

Host

  • 112
  • 104
  • 7
  • 6
Mouse

Clonality

  • 140
  • 86
  • 1
Monoclonal

Conjugate

  • 104
  • 26
  • 17
  • 16
  • 9
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CD59 antibody is un-conjugated

Application

  • 119
  • 97
  • 76
  • 58
  • 47
  • 40
  • 30
  • 29
  • 16
  • 14
  • 13
  • 13
  • 10
  • 9
  • 9
  • 8
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Grade

Carrier-free

Clone

MACIF-1193
  • Binding Specificity

    • 16
    • 13
    • 8
    • 6
    • 5
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    full length

    Purpose

    CD59 Antibody (azide and preservative free)

    No Cross-Reactivity

    Baboon, Horse (Equine)

    Characteristics

    Reacts with human CD59, a 20 kDa glycosyl phosphatidyl-inositol (GPI)-anchored cell surface protein. CD59 regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. CD59 is widely distributed on cells in all tissues. It inhibits formation of MAC, thus protecting cells from complement-mediated lysis. The expression of CD59 on erythrocytes is important for their survival. Genetic defects in GPI-anchor attachment, that cause a reduction or loss of CD59 and CD55 on erythrocytes produce the symptoms of the disease paroxysmal hemoglobinuria (PNH). It is useful for study on GPI-anchored proteins, PNH and CD59 functions.

    Purification

    PEG precipitation

    Immunogen

    Recombinant full-length human protein was used as the immunogen for the CD59 antibody.

    Isotype

    IgM, kappa
  • Application Notes

    Optimal dilution of the CD59 antibody should be determined by the researcher.

    1. Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM Citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 min.
    2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL

    Buffer

    1 mg/mL in 1X PBS, BSA free, sodium azide free

    Preservative

    Azide free

    Storage

    4 °C,-20 °C

    Storage Comment

    Store the CD59 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
  • Target

    CD59

    Alternative Name

    CD59

    Background

    Reacts with human CD59, a 20 kDa glycosyl phosphatidyl-inositol (GPI)-anchored cell surface protein. CD59 regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. CD59 is widely distributed on cells in all tissues. It inhibits formation of MAC, thus protecting cells from complement-mediated lysis. The expression of CD59 on erythrocytes is important for their survival. Genetic defects in GPI-anchor attachment, that cause a reduction or loss of CD59 and CD55 on erythrocytes produce the symptoms of the disease paroxysmal hemoglobinuria (PNH). It is useful for study on GPI-anchored proteins, PNH and CD59 functions.

    UniProt

    P13987

    Pathways

    Complement System
You are here:
Chat with us!